研究单位：[1]Changhai Hospital[2]The First Hospital of Jilin University[3]Zhuhai Tonbridge Medical Tech. Co., Ltd.[4]The First Affiliated Hospital of Henan Science ＆ Technology University,Luoyang,Henan,China[5]Zhongnan Hospital of Wuhan University,Wuhan,Hubei,China[6]Nanjing Drum Tower Hospital,Nanjing,Jiangsu,China[7]Jiangxi Provincial People''s Hospital,Nanchang,Jiangxi,China[8]The First Hospital of Jilin University,Changchun,Jilin,China[9]The First Affiliated Hospital of Dalian Medical University,Dalian,Liaoning,China[10]Baotou City Central Hospital,Baotou,Neimenggu,China[11]First Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,China[12]Hangzhou First People''s Hospital,Hangzhou,Zhejiang,China[13]Ningbo First Hospital,Ningbo,Zhejiang,China[14]Changhai Hospital of Shanghai,Shanghai,China[15]Shanghai Fourth People''s Hospital,Shanghai,China[16]Tongji Hospitai of Tongji University,Shanghai,China
研究目的：
The purpose of this study is to verify the efficacy and safety of the Intracranial Stent (Tonbridge) in endovascular treatment of symptomatic intracranial atherosclerotic stenosis.
